| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892
The expression of genes involved in p53-mediated apoptosis was studied using cDNA microarray after treating isogenic cell lines with either ionizing radiation or doxorubicin. Most of the known p53 transcriptional activation target genes clustered in a functional category defined by early and p53-dependent induction, regardless of the type of stress. Apoptotic protease activating factor-1 (APAF-1) emerged from this analysis as a novel p53 target gene. Genomic sequences upstream of the APAF-1 transcription start site contain a classic p53-responsive element that bound to p53. Consistently, p53 directly induced APAF-1 gene expression. Furthermore, DNA damage-mediated induction of APAF-1 mRNA and protein expression, accompanied by apoptosis, were strictly dependent on wild-type p53 function. These data are consistent with the hypothesis that APAF-1 is an essential downstream effector of p53-mediated apoptosis.
This article has been cited by other articles:
![]() |
E. A. O'Brien, V. Barnes, L. Zhao, R. A. McKnight, X. Yu, C. W. Callaway, L. Wang, J. C. Sun, M. J. Dahl, A. Wint, et al. Uteroplacental insufficiency decreases p53 serine-15 phosphorylation in term IUGR rat lungs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R314 - R322. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-G. Deng, H. Kawashima, G. Wu, G. Jayachandran, K. Xu, J. D. Minna, J. A. Roth, and L. Ji Synergistic Tumor Suppression by Coexpression of FUS1 and p53 Is Associated with Down-regulation of Murine Double Minute-2 and Activation of the Apoptotic Protease-Activating Factor 1-Dependent Apoptotic Pathway in Human Non-Small Cell Lung Cancer Cells Cancer Res., January 15, 2007; 67(2): 709 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Robles, M. H. Wright, B. Gandhi, S. S. Feis, C. L. Hanigan, A. Wiestner, and L. Varticovski Schedule-Dependent Synergy between the Heat Shock Protein 90 Inhibitor 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin and Doxorubicin Restores Apoptosis to p53-Mutant Lymphoma Cell Lines. Clin. Cancer Res., November 1, 2006; 12(21): 6547 - 6556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuarai, K. Yamanaka, and H. Kotani Mutant p53 Induces the GEF-H1 Oncogene, a Guanine Nucleotide Exchange Factor-H1 for RhoA, Resulting in Accelerated Cell Proliferation in Tumor Cells. Cancer Res., June 15, 2006; 66(12): 6319 - 6326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Baek, J.-S. Kim, S. M. Moore, S.-H. Lee, J. Martinez, and T. E. Eling Cyclooxygenase Inhibitors Induce the Expression of the Tumor Suppressor Gene EGR-1, Which Results in the Up-Regulation of NAG-1, an Antitumorigenic Protein Mol. Pharmacol., February 1, 2005; 67(2): 356 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wesierska-Gadek, M. Gueorguieva, and M. Horky Roscovitine-induced up-regulation of p53AIP1 protein precedes the onset of apoptosis in human MCF-7 breast cancer cells Mol. Cancer Ther., January 1, 2005; 4(1): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, A. N. Hanks, K. Boucher, S. R. Florell, S. M. Allen, A. Alexander, D. E. Brash, and D. Grossman UVB-induced apoptosis drives clonal expansion during skin tumor development Carcinogenesis, January 1, 2005; 26(1): 249 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zanon, A. Piris, I. Bersani, C. Vegetti, A. Molla, A. Scarito, and A. Anichini Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents Cancer Res., October 15, 2004; 64(20): 7386 - 7394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Lee, D. K. Ho, P. Zanassi, G. S. Walsh, D. R. Kaplan, and F. D. Miller Evidence That {Delta}Np73 Promotes Neuronal Survival by p53-Dependent and p53-Independent Mechanisms J. Neurosci., October 13, 2004; 24(41): 9174 - 9184. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Q. Li, A. I. Robles, C. L. Hanigan, L. J. Hofseth, L. J. Trudel, C. C. Harris, and G. N. Wogan Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-Type or Mutant p53 Cancer Res., May 1, 2004; 64(9): 3022 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Hofseth, A. I. Robles, Q. Yang, X. W. Wang, S. P. Hussain, and C. Harris p53: At the Crossroads of Molecular Carcinogenesis and Molecular Epidemiology Chest, May 1, 2004; 125(5_suppl): 83S - 85S. [Full Text] [PDF] |
||||
![]() |
S. P. Hussain, P. Amstad, P. He, A. Robles, S. Lupold, I. Kaneko, M. Ichimiya, S. Sengupta, L. Mechanic, S. Okamura, et al. p53-Induced Up-Regulation of MnSOD and GPx but not Catalase Increases Oxidative Stress and Apoptosis Cancer Res., April 1, 2004; 64(7): 2350 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fujimoto, H. Takeuchi, B. Taback, E. C. Hsueh, D. Elashoff, D. L. Morton, and D. S. B. Hoon Allelic Imbalance of 12q22-23 Associated with APAF-1 Locus Correlates with Poor Disease Outcome in Cutaneous Melanoma Cancer Res., March 15, 2004; 64(6): 2245 - 2250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Macip, M. Igarashi, P. Berggren, J. Yu, S. W. Lee, and S. A. Aaronson Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions Mol. Cell. Biol., December 1, 2003; 23(23): 8576 - 8585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt Apoptosis - the p53 network J. Cell Sci., October 15, 2003; 116(20): 4077 - 4085. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huigsloot, I. B. Tijdens, G. J. Mulder, and B. van de Water Differential Regulation of Doxorubicin-induced Mitochondrial Dysfunction and Apoptosis by Bcl-2 in Mammary Adenocarcinoma (MTLn3) Cells J. Biol. Chem., September 20, 2002; 277(39): 35869 - 35879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Q. Li, L. J. Trudel, and G. N. Wogan Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53 PNAS, August 6, 2002; 99(16): 10364 - 10369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. MacLachlan and W. S. El-Deiry Apoptotic threshold is lowered by p53 transactivation of caspase-6 PNAS, July 9, 2002; 99(14): 9492 - 9497. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pyrzynska, M. Serrano, C. Martinez-A., and B. Kaminska Tumor Suppressor p53 Mediates Apoptotic Cell Death Triggered by Cyclosporin A J. Biol. Chem., April 12, 2002; 277(16): 14102 - 14108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Baek, L. C. Wilson, and T. E. Eling Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53 Carcinogenesis, March 1, 2002; 23(3): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |